Ambu A/S (OTCMKTS:AMBBY) Shares Gap Up - Should You Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report)'s share price gapped up prior to trading on Wednesday . The stock had previously closed at $14.74, but opened at $15.55. Ambu A/S shares last traded at $15.55, with a volume of 500 shares trading hands.

Analysts Set New Price Targets

Separately, UBS Group upgraded shares of Ambu A/S to a "strong-buy" rating in a research note on Tuesday, May 13th.

Ambu A/S Trading Up 5.5%

The stock has a market cap of $3.65 billion, a price-to-earnings ratio of 81.85 and a beta of 1.00. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.67 and a current ratio of 2.88. The company's 50 day simple moving average is $15.72 and its two-hundred day simple moving average is $16.67.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share for the quarter. Ambu A/S had a net margin of 6.21% and a return on equity of 6.31%.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.